The wealthy individuals who purchased anti-gravity devices also garnered a lot of attention, inviting reporters to experience weightlessness and giving interviews, which guaranteed them front-page exposure.
This in turn sparked even more interest among other rich folks, with orders for the Aviation Group’s personal anti-gravity equipnt backlogged for two years.
Hold on.
Anti-gravity technology was the real focal point of public interest.
anwhile, Zhao Yi was conducting his research quite quietly, and soon there was news related to him, or to be precise, related to Zhao Yi’s laboratory.
Zhao Yi’s laboratory announced research progress, declaring they had found a universal thod to immunotherapy-based cancer treatnt. By extracting specific proteins from bats and introducing them into the human bloodstream, they could effectively inhibit the spread of cancer cells.
This announcent sparked huge attention.
Zhao Yi’s laboratory had already beco internationally recognized as a top-tier dical research facility, and any developnt update they released received a lot of attention.
The release of information about the discovery of a novel cancer treatnt thod, especially one that could effectively check the spread of cancer cells, caused a significant stir.
That’s when the impact was truly felt.
Once the news was officially released, the stock prices of companies relying on the production of chemotherapy equipnt, anti-cancer drugs, and immunotherapies promptly plumted, so small companies even falling more than twenty percent.
International dia covered the story in detail, and plenty of reporters visited the dical center for interviews, obtaining firsthand information.
In fact, the developnt process was still ongoing.
The current stage had only confird that the protein extracted from bat bodies was highly effective in clearing cancer cells from the blood.
This stage in the process indicated that it would take at least a year before the related dicine could hit the market, as a considerable amount of testing, research for mass drug manufacturing, and drug approval procedures would all be required, which could take five years or more.
However, subsequent research could no longer be conducted solely by the laboratory.
The laboratory had decided to collaborate with pharmaceutical companies to not only scale up the drug trials but to also allow the companies to begin research on mass protein extraction and synthetic protein production in advance.
Soon after.
The laboratory found a pharmaceutical partner and signed a related cooperation agreent.
Since the initial research by the laboratory had already proven the protein’s effectiveness in treating cancer, the agreent was very favorable for the research team.
First of all, they recouped research funding.
The partnering pharmaceutical company provided five hundred million as initial funding, and all subsequent joint research expenses were also paid by the company.
The reason for such a substantial initial investnt of five hundred million was primarily due to the broad prospects of the drug; it could effectively inhibit the proliferation of cancer cells. This one benefit was enough to dominate the ’cancer chemotherapy’ market, as its comrcial potential was just too great.
Then there was the matter of patents.
The agreent stipulated that the research team would receive fifteen percent of the drug’s sales revenue for a duration of five years after the drug went to market.
The key here was ’sales’, not ’profit’, aning if the drug sold for a hundred billion, the research team would receive fifteen billion.
Although it was just a short five-year span, it was undoubtedly a vast profit.
The rest were various research-related detail clauses, and within the Biodical Research Institute, there was an allocation of benefits.
During the earlier research phase, the Research Institute invested ten million, the laboratory put in thirty million, and Zhao Yi personally contributed ten million.
The final distribution plan was that, for the subsequent patent revenue sharing, Zhao Yi personally received three percentage points, the Biodical Research Institute also received three percentage points, and the laboratory received nine percentage points.
In addition, there was the initial five hundred million in research and developnt funds.
This chunk of funding was of little concern to the Biodical Research Institute, or it could even be said to have ’no relation whatsoever,’ because the project was owned by the laboratory. The Biodical Research Institute would enjoy patent revenue sharing, but the funding was fed back to the ’research team,’ which could be understood as solely the laboratory’s.
However, Zhao Yi still decided to allocate twenty million to the Biodical Research Institute, "Investing ten million, and in just over half a year, reaping twenty million, Director Yan, you really know how to do business, earning big for the institute!"
Yan Xuelin didn’t know whether to cry or laugh; as Zhao Yi said, with an investnt of ten million in funding, a return of twenty million was realized in just half a year, on top of enjoying three percentage points of patent revenue sharing, which would definitely bring a continuous stream of significant profits in the future.
Now, the Biodical Research Institute’s annual patent inco easily exceeds two billion yuan, making it the wealthiest biodical research institution in the country.
Could it perhaps reach five billion, ten billion, or even more in the future?
Yan Xuelin was very much looking forward to it.
But without comparison, there would be no hurt.
Zhao Yi’s laboratory seed to be hinting at independence, at the very least financially independent, since they had more money than the Biodical Research Institute.
While the Biodical Research Institute’s inco was high, it also had to ’support’ over a dozen laboratories; several billion in funds might sound like a lot, but the expenses were also substantial. Just the project investnts exceeded one billion, not to ntion the costs of expansion, increasing personnel, equipnt maintenance, daily managent, logistics support, and so on, all requiring funds.
How about Zhao Yi’s laboratory?
There were only five researchers, and including a pair of associate researchers and intern researchers, not more than a couple dozen people in total.
The laboratory equipnt maintenance and logistics support were all paid for by the Biodical Research Institute.
anwhile, Zhao Yi’s laboratory easily secured thirty million for research and developnt, and the annual inco it generated was no less than that of the Biodical Research Institute.
In the future, it would surely be even more!
Nine percentage points!
The thought alone made Yan Xuelin’s heart bleed. He deeply regretted not having allocated all the funds for support since the Biodical Research Institute could have scraped together the fifty million for research and developnt by tightening its belt.
Of course.
Zhao Yi’s laboratory was alight with excitent, securing over four hundred million in one go, with most of it deposited into the laboratory account, and the remainder taken out by Zhao Yi as a bonus distribution.
The Biodical Research Institute as a university-affiliated research institution, equal to a state-supported organization, had upper limits set for scientific personnel salaries and bonuses.
But no matter!
Zhao Yi decided to provide each researcher with a set of guaranteed housing; though it was called housing guarantee, in reality, he had purchased an entire newly opened building in the vicinity, allocating an apartnt to each researcher. He also announced, "In the future, associate researchers who have made ample R&D contributions can also apply for ’guaranteed’ housing."
Upon hearing the news, other laboratories suddenly felt a pang of jealousy.
Dai Tianqing even went out of his way to find Yan Xuelin, expressing his wish to join Zhao Yi’s laboratory team. After being sternly refused with a darkened face, he even suggested that Yan Xuelin ’resign’.
"How about this, let Zhao Yi beco the director. Old Yan, I think you can consider an early, honorable retirent."
"Once Zhao Yi takes over as director..."
"Yada yada yada~"
In the end, Dai Tianqing was kicked out of the director’s office.
Reviews
All reviews (0)